7-2519788-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001040167.2(LFNG):c.-74C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00223 in 900,606 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0098 ( 21 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 11 hom. )
Consequence
LFNG
NM_001040167.2 5_prime_UTR
NM_001040167.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.40
Genes affected
LFNG (HGNC:6560): (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) This gene is a member of the glycosyltransferase 31 gene family. Members of this gene family, which also includes the MFNG (GeneID: 4242) and RFNG (GeneID: 5986) genes, encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, these proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. The protein encoded by this gene is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. [provided by RefSeq, May 2018]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 7-2519788-C-G is Benign according to our data. Variant chr7-2519788-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 1706904.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00981 (1463/149090) while in subpopulation AFR AF = 0.0339 (1396/41240). AF 95% confidence interval is 0.0324. There are 21 homozygotes in GnomAd4. There are 706 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LFNG | NM_001040167.2 | c.-74C>G | 5_prime_UTR_variant | Exon 1 of 8 | ENST00000222725.10 | NP_001035257.1 | ||
LFNG | NM_001040168.2 | c.-74C>G | 5_prime_UTR_variant | Exon 1 of 8 | NP_001035258.1 | |||
LFNG | NM_001166355.2 | c.220-4907C>G | intron_variant | Intron 2 of 8 | NP_001159827.1 | |||
LFNG | NM_002304.3 | c.45+1190C>G | intron_variant | Intron 2 of 8 | NP_002295.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00981 AC: 1462AN: 148984Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1462
AN:
148984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000723 AC: 543AN: 751516Hom.: 11 AF XY: 0.000635 AC XY: 223AN XY: 351248 show subpopulations
GnomAD4 exome
AF:
AC:
543
AN:
751516
Hom.:
AF XY:
AC XY:
223
AN XY:
351248
Gnomad4 AFR exome
AF:
AC:
480
AN:
14092
Gnomad4 AMR exome
AF:
AC:
8
AN:
1456
Gnomad4 ASJ exome
AF:
AC:
0
AN:
5286
Gnomad4 EAS exome
AF:
AC:
0
AN:
6038
Gnomad4 SAS exome
AF:
AC:
0
AN:
14976
Gnomad4 FIN exome
AF:
AC:
0
AN:
3122
Gnomad4 NFE exome
AF:
AC:
24
AN:
679680
Gnomad4 Remaining exome
AF:
AC:
31
AN:
25266
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00981 AC: 1463AN: 149090Hom.: 21 Cov.: 32 AF XY: 0.00971 AC XY: 706AN XY: 72736 show subpopulations
GnomAD4 genome
AF:
AC:
1463
AN:
149090
Hom.:
Cov.:
32
AF XY:
AC XY:
706
AN XY:
72736
Gnomad4 AFR
AF:
AC:
0.0338506
AN:
0.0338506
Gnomad4 AMR
AF:
AC:
0.0034524
AN:
0.0034524
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000449438
AN:
0.0000449438
Gnomad4 OTH
AF:
AC:
0.00579151
AN:
0.00579151
Heterozygous variant carriers
0
75
149
224
298
373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 25, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at